MELEDDU, RITA
 Distribuzione geografica
Continente #
EU - Europa 179.470
NA - Nord America 5.720
AS - Asia 2.550
SA - Sud America 361
AF - Africa 141
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 188.249
Nazione #
IT - Italia 177.775
US - Stati Uniti d'America 5.631
SG - Singapore 981
CN - Cina 913
SE - Svezia 410
UA - Ucraina 380
BR - Brasile 277
DE - Germania 269
VN - Vietnam 219
FI - Finlandia 176
FR - Francia 129
GB - Regno Unito 126
HK - Hong Kong 107
IN - India 90
MA - Marocco 83
CA - Canada 44
KR - Corea 44
BD - Bangladesh 36
AT - Austria 34
NL - Olanda 33
MX - Messico 30
AR - Argentina 26
ZA - Sudafrica 25
PK - Pakistan 24
RU - Federazione Russa 24
PL - Polonia 21
IQ - Iraq 19
JP - Giappone 19
ID - Indonesia 16
TR - Turchia 15
VE - Venezuela 15
CO - Colombia 14
ES - Italia 14
IE - Irlanda 14
BE - Belgio 13
CZ - Repubblica Ceca 11
SA - Arabia Saudita 11
EC - Ecuador 9
PH - Filippine 9
UZ - Uzbekistan 8
EG - Egitto 7
KE - Kenya 7
PT - Portogallo 7
PY - Paraguay 7
LT - Lituania 6
TN - Tunisia 6
CL - Cile 5
ET - Etiopia 5
IR - Iran 5
JO - Giordania 5
RO - Romania 5
AL - Albania 4
MY - Malesia 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
BO - Bolivia 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
IL - Israele 2
IS - Islanda 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A1 - Anonimo 1
AU - Australia 1
AW - Aruba 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CM - Camerun 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
SI - Slovenia 1
SL - Sierra Leone 1
Totale 188.245
Città #
Cagliari 174.758
Uta 2.658
Ashburn 522
Singapore 513
Fairfield 463
Woodbridge 399
Chandler 348
Dallas 347
San Jose 331
Nyköping 261
Houston 249
Ann Arbor 238
Wilmington 224
Boardman 209
Seattle 206
Jacksonville 184
Beijing 181
Cambridge 149
Dearborn 136
New York 119
Los Angeles 118
Helsinki 108
Hong Kong 99
Shanghai 94
Santa Clara 86
Casablanca 78
Nanjing 75
Ho Chi Minh City 72
The Dalles 72
Council Bluffs 70
Lauterbourg 69
Boston 59
Hefei 50
Seoul 43
Hanoi 41
Munich 40
Redwood City 34
San Diego 32
Buffalo 30
Verona 30
Amsterdam 29
Vienna 28
Shenyang 27
São Paulo 27
Dong Ket 24
Frankfurt am Main 24
Milan 24
Chennai 23
Changsha 20
Orem 20
Nanchang 19
Warsaw 19
Guangzhou 18
Jiaxing 17
Redondo Beach 17
London 16
Sassari 16
Toronto 16
Hebei 15
Chicago 14
Herndon 14
Jinan 14
Nuremberg 14
Tokyo 14
Dublin 13
Mountain View 13
Phoenix 13
Tianjin 13
Zhengzhou 13
Brooklyn 12
Brussels 11
Gujranwala 11
Johannesburg 11
Kunming 11
Mexico City 11
Norwalk 11
Atlanta 10
Rio de Janeiro 10
Haiphong 9
Montreal 9
Mumbai 9
San Francisco 9
Washington 9
Auburn Hills 8
Da Nang 8
Rome 8
Tashkent 8
Turku 8
Wuhan 8
Bengaluru 7
Denver 7
Jakarta 7
Lappeenranta 7
Manchester 7
Ningbo 7
Baghdad 6
Brno 6
Caracas 6
Columbus 6
Durban 6
Totale 184.592
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.721
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.057
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.693
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.680
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.522
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.443
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.406
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.329
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.316
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.184
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.934
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.780
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.777
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.608
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.539
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.538
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.423
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.371
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.337
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.306
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.283
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.217
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.200
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 3.037
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 3.036
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.035
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.970
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.920
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.909
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.770
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.630
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.612
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.548
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.457
New promising scaffolds for the inhibition of monoamine oxidase B 2.305
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.260
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.149
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.138
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.099
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.069
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 2.000
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.968
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.956
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.919
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.881
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.814
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.810
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.796
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.736
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.705
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.685
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.635
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.628
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.613
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.611
From classic to innovative approaches in HIV-1 infection treatment 1.557
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.548
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.519
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.514
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.198
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.113
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.077
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 997
Synthesis of different series of small molecules targeting HIV-1 RT, Candida albicans, MAO and G-Quadruplex 985
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 939
5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action 870
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 786
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives 760
Suppression of lipopolysaccharide-induced COX-2 expression via p38MAPK, JNK, and C/EBPβ phosphorylation inhibition by furomagydarin A, a benzofuran glycoside from Magydaris pastinacea 639
2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms 424
New Structural Features of Isatin Dihydrothiazole Hybrids for Selective Carbonic Anhydrase Inhibitors 287
Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors 281
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B 278
Tiazolidinoni come agenti antivirali 156
Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases 150
Identifying potential allosteric inhibitors of ZIKV NS3pro through a combined computational and biochemical approach 58
Chromones as Nonclassical Inhibitors of Carbonic Anhydrase IX and XII Isoforms: Probing Chromone-Based Derivatives 15
Totale 188.516
Categoria #
all - tutte 215.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.348 0 0 0 0 0 0 0 0 0 2.434 2.581 1.333
2021/20228.064 1.004 734 401 542 710 557 445 382 689 764 894 942
2022/202312.945 1.117 1.853 1.685 1.379 868 1.346 675 1.036 762 691 1.076 457
2023/202411.424 523 367 816 816 1.081 2.108 1.464 934 723 706 858 1.028
2024/202536.787 13.803 11.583 4.410 2.369 1.081 1.764 831 114 261 184 147 240
2025/20265.674 471 253 755 549 535 362 800 586 456 907 0 0
Totale 188.516